Board of Directors

Mr. Jain joined the Company in February 2014 as Chairman of the Board and Chief Executive Officer.

Mr. Greenberg is currently serving as Chief Executive Officer of HomeThrive, Inc. Mr. Greenberg joined HomeThrive, Inc. in 2018 and serves on the board of directors. Mr. Greenberg  previously served as Executive Vice President of Strategy for Medline Industries, Inc. from June 2008 to October 2018 and was a member of their Executive Board, advising top leadership on all aspects of the business. Mr. Greenberg was also responsible for Strategy, Business Development,  M&A and was a Group President overseeing Medline's distribution business, including several manufacturing and marketing divisions.

Elisha Finney served as Executive Vice President, Finance and Chief Financial Officer of Varian Medical Systems (“Varian”) for 29 years. Ms. Finney joined Varian in 1988 and assumed a wide variety of finance functions over her 29 years with the company. Ms. Finney also serves on the Board of NanoString Technologies, Mettler Toledo,  and Viatris has previously served on the Board of Directors of iRobot Corporation, Cutera, Inc., Laserscope Inc., Thoratec Corporation, Altera Corporation, and Varex Imaging Corporation.

Mr. Abbey is currently serving as Executive Vice President, Quality and Information Technology at Dexcom, Inc. (“Dexcom”). Mr. Abbey joined Dexcom in May of 2016. Initially, upon joining Dexcom Mr. Abbey was Executive Vice President, Quality until January of 2017 when he was promoted to his current position. Prior to joining Dexcom, Mr. Abbey was with Becton Dickinson (who acquired CareFusion Corporation in 2015 and which was spun out of Cardinal Health in 2009 (collectively, “BD”)) from 2007. Mr. Abbey served in many roles over his years at BD including most recently as the Senior Vice President, Quality and Regulatory. Prior to his time at BD, Mr. Abbey held senior quality and regulatory affairs and general management positions with Respironics, Welch Allyn and Philips Healthcare. Mr. Abbey began his career at Varian Medical and Boston Scientific holding positions with increasing responsibility in research and development and quality.

Mr. Hoffmeister served as Senior Vice President and Chief Financial Officer of Life Technologies Corp. from 2004 to 2014. Prior to joining Life Technologies, Mr. Hoffmeister was a senior partner with McKinsey & Co., focusing on health care, private equity and chemicals industries. Before joining McKinsey, Mr. Hoffmeister held financial positions at GTE Corp. and W.R. Grace and Co. Mr. Hoffmeister currently serves on the boards of Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals and has since November of 2014. Mr. Hoffmeister currently serves on the Board of Directors of Glaukos Corp. and has since 2014. Mr. Hoffmeister also serves on the Board of Directors for Celanese Corp. since 2005 and Stepstone Group, Inc, since 2020.

Ms. Hernandez is a retired healthcare executive with over 25 years of strategic healthcare experience. She joined Baxter Healthcare Corporation (“Baxter”) in November of 2007 and assumed a wide variety of strategic positions over her 10 years with that company. Prior to joining Baxter, Ms. Hernandez was with Hospira Inc. in Lake Forest, Illinois. Ms. Hernandez previously served on the boards of Sinai Health System in Chicago and Lambs Farm in Libertyville, IL.

Ms. Kennedy served as President, Proton Solutions & Chief Growth Office at Varian Medical Systems (“Varian”) from 2018 until December 31, 2021 when she retired. Ms. Kennedy joined Varian in 1997 as Marketing Manager for radiation therapy delivery systems, and assumed other strategic roles including President of Varian Oncology Systems. Prior to joining Varian, Ms. Kennedy was with Siemens Medical and Radiation Oncology Computer Systems in radiation oncology product sales and marketing. Ms. Kennedy currently serves on the boards of IPG Photonics since 2023, of Wayne State University Foundation since 2018, and served on the boards of the City Cancer Challenge Foundation from 2018 to 2022, and Radiation Oncology Institute from 2018 to 2021.